Cargando…
IgA Nephropathy in a Patient Treated with Adalimumab
Immunoglobulin A (IgA) nephropathy (IgAN) is the most common glomerulonephritis worldwide, characterized by IgA deposits in the glomerular mesangium. It has a progressive nature and can eventually lead to end-stage kidney failure. It can occur as a potential side effect of treatment with tumor necro...
Autores principales: | Mertelj, Tonja, Smrekar, Nataša, Kojc, Nika, Lindič, Jelka, Kovač, Damjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436610/ https://www.ncbi.nlm.nih.gov/pubmed/34595210 http://dx.doi.org/10.1159/000515585 |
Ejemplares similares
-
IgA Nephropathy Secondary to Ipilimumab Use
por: Dougherty, Sean C., et al.
Publicado: (2021) -
Uromodulin and microRNAs in Kidney Transplantation—Association with Kidney Graft Function
por: Borštnar, Špela, et al.
Publicado: (2020) -
An Overlooked Link between IgA Nephropathy and Lithium Toxicity: A Case Report
por: Mehandru, Sushil K., et al.
Publicado: (2021) -
Refractory Cutaneous IgA Vasculitis Treated with Omega-3 Fatty Acids
por: Barnadas, M. A., et al.
Publicado: (2016) -
Listeria Monocytogenes Brain Abscess in Crohn's Disease Treated with Adalimumab
por: Atsawarungruangkit, Amporn, et al.
Publicado: (2017)